CureMatch
×
  • Physicians
  • BioPharma
  • Employers
  • News
  • Clinical Order
  • About Us
  • Login
Nick Bellanca

Nick Bellanca

Vice President | Employee Health & Benefits

Nick Bellanca is a Vice President of Employee Health & Benefits at Marsh McLennan Agency (MMA). He specializes in healthcare plan design, benefits and total rewards consulting for employer groups. With 18 years in the industry, Nick leverages data analytics, benefits education and engagement to deliver creative solutions that help employers attract and retain talent while containing costs.

Prior to joining MMA, Nick was a founding member of Genomic Life, and led their group benefits division. While at Genomic Life, he helped create their unique Cancer Guardian program, designed their go-to market strategy and led their national sales efforts in the employer market. Nick also spent 12 years at Unum as an award winning large employer group specialist, focused on Disability, Absence Management, Life Insurance, and Voluntary Benefits.

Nick earned his B.A. in Accounting from the University of San Diego. He is a SHRM Senior Certified Professional (SHRM-SCP) and a Group Benefits Disability Specialist (GBDS). He is also a member of the RAD Collective, Human Resources Association of Central Ohio (HRACO), National Association of Health Underwriters (NAHU) and the Society for Human Resource Management (SHRM). Nick has been featured by Leader’s Edge magazine and named a Top 40 Under 40 by the San Diego Business Journal. He has been a guest speaker at Biocom, CIAB, Employee Benefits Forum & Expo, Workplace Benefits Renaissance and other industry events on the topic of benefits innovation and personalized healthcare.

logo

+1 (858) 215-1313

Quick Links

  • Home
  • Physicians
  • About CureMatch
  • News and Latest Posts
  • Contact Us
  • FAQ

Latest News and Results

  • Launch of CureMatch Certified Precision Oncology Recognition Award May 8

    CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...

  • CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment Oct 7

    CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...

  • CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments Jun 28

    CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...

© 2025 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

Please fill out the information below and a CureMatch representative will reach out to you.

 

Physician Request

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data